ALC
Alcon·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 3
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Bearish Abandoned Baby
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ALC
Alcon Inc.
A global leader in eye care that offers a full suite of eye care products
Healthcare Equipment and Supplies
--
04/09/2019
New York Stock Exchange
25,599
12-31
Common stock
Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland
Development, production and sale of pharmaceuticals, surgical equipment and equipment, and consumer eye care products
Alcon Inc. was originally incorporated in Switzerland in 1971. Alcon is a global R & D-led medical professional company focused on eye care. The company develops, manufactures and sells pharmaceuticals, surgical equipment and devices, and consumer eye care products. The company's extensive product portfolio is one of the strongest in the ophthalmic industry, with high-quality and technologically advanced products in all major product categories. The company believes it has the largest commitment to ophthalmic research and development of any company in the world.
Earnings Call
Q1/2025
Estimate EPS0.77
Actual EPS0.73
Estimate Revenue2.52B
Actual Revenue2.45B
Alcon's Q1 2025 Earnings Call: Unraveling Contradictions in Market Performance and Growth Expectations
May 20,2025 10:08
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.72
Actual EPS0.76
Estimate Revenue2.64B
Actual Revenue2.60B
Alcon's Q2 2025 Earnings Call: Navigating Contradictions in Market Growth, Share Stability, and Economic Impact
Aug 20,2025 09:37
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS0.85
Actual EPS0.79
Estimate Revenue2.60B
Actual Revenue2.59B
Alcon's Q3 2025 Earnings Call: Contradictions Emerge on STAAR Acquisition Timelines, Unity Installations, and Systane Growth Projections
Nov 12,2025 01:52
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ALC has released its 2025 Q3 earnings. EPS was reported at 0.79, versus the expected 0.85, missing expectations. The chart below visualizes how ALC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ALC has released its 2025 Q3 earnings report, with revenue of 2.61B, reflecting a YoY change of 6.52%, and net profit of 237.00M, showing a YoY change of -9.89%. The Sankey diagram below clearly presents ALC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
